InnoCare Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2017
Period Ending	Jan '25 Jan 2, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2017
Market Capitalization	11,418	13,677	24,677	22,945	17,378	-	Upgrade
Market Cap Growth	17.30%	-44.57%	7.55%	32.04%	-	-	Upgrade
Enterprise Value	5,311	5,233	15,518	16,987	13,835	-	Upgrade
Last Close Price	5.52	6.89	13.64	15.30	13.48	-	Upgrade
PS Ratio	9.49	16.81	34.90	17.92	10727.94	-	Upgrade
PB Ratio	1.39	1.73	2.86	3.30	4.63	-	Upgrade
P/TBV Ratio	1.92	1.80	2.98	3.36	4.78	-	Upgrade
P/OCF Ratio	-	-	-	111.89	-	-	Upgrade
EV/Sales Ratio	5.33	6.43	21.95	13.27	8540.54	-	Upgrade
Debt / Equity Ratio	0.23	0.23	0.20	0.23	0.37	-1.81	Upgrade
Asset Turnover	0.09	0.07	0.07	0.17	0.00	0.00	Upgrade
Inventory Turnover	1.19	1.39	3.81	11.13	-	-	Upgrade
Quick Ratio	7.27	4.13	4.44	19.29	38.75	36.48	Upgrade
Current Ratio	7.74	4.21	4.50	19.49	39.18	36.68	Upgrade
Return on Equity (ROE)	-5.52%	-8.71%	-13.44%	-1.51%	-368.36%	-	Upgrade
Return on Assets (ROA)	-4.03%	-4.37%	-5.15%	-1.91%	-9.77%	-7.24%	Upgrade
Return on Capital (ROIC)	-4.88%	-4.91%	-5.65%	-2.02%	-10.37%	-7.70%	Upgrade
Earnings Yield	-2.99%	-5.08%	-4.06%	-0.35%	-2.67%	-	Upgrade
FCF Yield	-5.60%	-7.41%	-3.94%	-0.01%	-2.89%	-	Upgrade
Buyback Yield / Dilution	-0.57%	-15.46%	-8.15%	-41.20%	-321.19%	-18.13%	Upgrade
Total Shareholder Return	-0.57%	-15.46%	-8.15%	-41.20%	-321.19%	-18.13%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.